Soluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after antiretroviral therapy

Journal of Infectious Diseases

Volumn 204, Issue 1, 2011, Pages 154-163

  Burdo, Tricia H ^a   Lentz, Margaret R ^b   Autissier, Patrick ^a   Krishnan, Anitha ^a   Halpern, Elkan ^b   Letendre, Scott ^c   Rosenberg, Eric S ^b   Ellis, Ronald J ^c   Williams, Kenneth C ^a  

^a BOSTON COLLEGE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD38 ANTIGEN; HLA DR ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIMIT OF DETECTION; MACROPHAGE ACTIVATION; MALE; MONOCYTE; PRIORITY JOURNAL; SEROLOGY; VIRUS DETECTION; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BIOLOGICAL MARKERS; CHRONIC DISEASE; FEMALE; HIV INFECTIONS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; PLASMA; RECEPTORS, CELL SURFACE; RNA, VIRAL; VIRAL LOAD;

EID: 79957940339     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir214     Document Type: Article

References (48)

1. Christensen JE, Thomsen AR. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key. APMIS 2009; 117:338-55.
2. Hasegawa A, Liu H, Ling B, et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS. Blood 2009; 114:2917-25.
3. Williams KC, Hickey WF. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 2002; 25:537-62. (Pubitemid 34748028)
4. Veazey RS, Lackner AA. Getting to the guts of HIV pathogenesis. J Exp Med 2004; 200:697-700. (Pubitemid 39299456)
5. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006; 12:1365-71. (Pubitemid 44924494)
6. Ancuta P, Kamat A, Kunstman KJ, et al. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 2008; 3:e2516.
7. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. (Pubitemid 43261452)
8. Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 2008; 3:352-63. (Pubitemid 351773099)
9. Pichlmair A, Reis e Sousa C. Innate recognition of viruses. Immunity 2007; 27:370-83.
10. Zhao J, Yang X, Auh SL, Kim KD, Tang H, Fu YX. Do adaptive immune cells suppress or activate innate immunity? Trends Immunol 2009; 30:8-12.
11. Sachdeva M, Fischl MA, Pahwa R, Sachdeva N, Pahwa S. Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients. J Acquir Immune Defic Syndr 2010; 54:447-54.
12. Noursadeghi M, Katz DR, Miller RF. HIV-1 infection of mononuclear phagocytic cells: the case for bacterial innate immune deficiency in AIDS. Lancet Infect Dis 2006; 6:794-804. (Pubitemid 44894330)
13. Kristiansen M, Graversen JH, Jacobsen C, et al. Identification of the haemoglobin scavenger receptor. Nature 2001; 409:198-201. (Pubitemid 32144285)
14. Weaver LK, Hintz-Goldstein KA, Pioli PA, et al. Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 2006; 80:26-35. (Pubitemid 44835523)
15. Hintz KA, Rassias AJ, Wardwell K, et al. Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163. J Leukoc Biol 2002; 72:711-17. (Pubitemid 36277842)
16. Moller HJ, Peterslund NA, Graversen JH, Moestrup SK. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 2002; 99:378-80. (Pubitemid 34533008)
17. Backe E, Schwarting R, Gerdes J, Ernst M, Stein H. Ber-MAC3: new monoclonal antibody that defines human monocyte/macrophage differentiation antigen. J Clin Pathol 1991; 44:936-45.
18. Fabriek BO, van Bruggen R, Deng DM, et al. The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria. Blood 2009; 113:887-92.
19. Davis BH, Zarev PV. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels. Cytometry B Clin Cytom 2005; 63:16-22. (Pubitemid 40096840)
20. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell-surface Toll-like receptors. J Leukoc Biol 2007; 81:663-71. (Pubitemid 46393544)
21. Sulahian TH, Pioli PA, Wardwell K, Guyre PM. Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163. J Leukoc Biol 2004; 76:271-7. (Pubitemid 38857196)
22. Timmermann M, Hogger P. Oxidative stress and 8-iso-prostaglandin F(2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radic Biol Med 2005; 39:98-107. (Pubitemid 40733120)
23. Droste A, Sorg C, Hogger P. Shedding of CD163, a novel regulatory mechanism for a member of the scavenger receptor cysteine-rich family. Biochem Biophys Res Commun 1999; 256:110-3. (Pubitemid 29298926)
24. Etzerodt A, Maniecki MB, Moller K, Moller HJ, Moestrup SK. Tumor necrosis factor alpha-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol 2010; 88:1201-5.
25. Moller HJ, de Fost M, Aerts H, Hollak C, Moestrup SK. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol 2004; 72:135-9. (Pubitemid 38161162)
26. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol 2000; 67:97-103. (Pubitemid 30046823)
27. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS. Unique monocyte subset in patients with AIDS dementia. Lancet 1997; 349:692-5. (Pubitemid 27107748)
28. Kim WK, Sun Y, Do H, et al. Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 2009; 87:557-67.
29. Burdo TH, Soulas C, Orzechowski K, et al. Increased monocyte turn-over from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 2010; 6:e1000842.
30. Kim WK, Alvarez X, Fisher J, et al. CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood. Am J Pathol 2006; 168:822-34. (Pubitemid 43327735)
31. Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J. Monocyte/ macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 2008; 14:318-26.
32. Lentz MR, Kim WK, Lee V, et al. Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 2009; 72:1465-72.
33. Kassutto S, Rosenberg ES. Primary HIV type 1 infection. Clin Infect Dis 2004; 38:1447-53. (Pubitemid 38668592)
34. Alter G, Teigen N, Ahern R, et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 2007; 195:1452-60. (Pubitemid 46717463)
35. Sulahian TH, Hogger P, Wahner AE, et al. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000; 12:1312-21.
36. Knudsen TB, Gustafson P, Kronborg G, et al. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect 2005; 11:730-5. (Pubitemid 41167339)
37. Delanghe JR, Philippe J, Moerman F, et al. Impaired hemoglobin scavenging during an acute HIV-1 retroviral syndrome. Clin Chim Acta 2010; 411:521-3.
38. Sonza S, Mutimer HP, Oelrichs R, et al. Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 2001; 15:17-22. (Pubitemid 32055775)
39. Harrold SM, Wang G, McMahon DK, et al. Recovery of replication-competent HIV type 1-infected circulating monocytes from individuals receiving antiretroviral therapy. AIDS Res Hum Retroviruses 2002; 18:427-34. (Pubitemid 34493908)
40. Zhu T, Muthui D, Holte S, et al. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy. J Virol 2002; 76:707-16. (Pubitemid 34033369)
41. Lova L, Groff A, Ravot E, et al. Hydroxyurea exerts a cytostatic but not immunosuppressive effect on T lymphocytes. AIDS 2005; 19:137-44. (Pubitemid 40409532)
42. Perno CF, Svicher V, Schols D, Pollicita M, Balzarini J, Aquaro S. Therapeutic strategies towards HIV-1 infection in macrophages. Antiviral Res 2006; 71:293-300. (Pubitemid 44223775)
43. Fischer-Smith T, Croul S, Sverstiuk AE, et al. CNS invasion by CD14+/ CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001; 7:528-41.
44. Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N. CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 1995; 25:3418-24.
45. Wallet MA, Rodriguez CA, Yin L, et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T-cell activation following therapy. AIDS 2010; 24:1281-90.
46. Baroncelli S, Galluzzo CM, Pirillo MF, et al. Microbial translocation is associated with residual viral replication in HAART-treated HIV1 subjects with <50copies/ml HIV-1 RNA. J Clin Virol 2009; 46:367-70.
47. Madsen M, Moller HJ, Nielsen MJ, et al. Molecular characterization of the haptoglobin.hemoglobin receptor CD163. Ligand binding properties of the scavenger receptor cysteine-rich domain region. J Biol Chem 2004; 279:51561-7. (Pubitemid 40017906)
48. Hogger P, Sorg C. Soluble CD163 inhibits phorbol ester-induced lymphocyte proliferation. Biochem Biophys Res Commun 2001; 288:841-3. (Pubitemid 33140958)